Mark Dysinger

Alexion Pharmaceuticals

Ligand binding assay validation requirements and strategies

Watch this presentation by Mark Dysinger, Associate Director at Alexion Pharmaceuticals, titled: Ligand binding assay validation requirements and strategies. This talk was presented at the SelectScience® Virtual Biopharmaceuticals Summit 2022.



LIKE 0
Mark Dysinger
Biotherapeutics Drug Discovery

Mark Dysinger

Biography

Mark Dysinger is the associate director at Alexion Pharmaceuticals in New Haven, Connecticut. More
Follow Mark

Mark Dysinger

Alexion Pharmaceuticals

Mark Dysinger is the associate director at Alexion Pharmaceuticals in New Haven, Connecticut. In this role, he is a bioanalytical project representative for novel rare disease drug therapies and is heavily involved in method development, assay validation, and sample analysis for both preclinical and clinical trials. Mark has over 20 years’ experience in the pharmaceutical industry and holds a Master of Science degree in biotechnology from the University of Maryland University College and a bachelor’s degree in zoology from the University of Maine.